Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Regulation of ERK1/2 and SAPK/JNK phosphorylation by histamine
by
Dandekar, Radhika D
in
Pharmacology
2009
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Regulation of ERK1/2 and SAPK/JNK phosphorylation by histamine
by
Dandekar, Radhika D
in
Pharmacology
2009
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Regulation of ERK1/2 and SAPK/JNK phosphorylation by histamine
Dissertation
Regulation of ERK1/2 and SAPK/JNK phosphorylation by histamine
2009
Request Book From Autostore
and Choose the Collection Method
Overview
Mitogen activated protein kinases (MAPKs) are specific serine/threonine kinases which respond to various stimuli and control various cellular activities including gene expression, mitosis, cell differentiation, and cell survival/apoptosis. Histamine is implicated in allergic disease and asthma and SAPK/JNK and ERK1/2 are involved in certain aspects of allergic inflammation such as TH2 differentiation and proliferation and apoptosis. This study was designed to investigate the effects of histamine on ERK1/2 and SAPK/JNK phosphorylation in splenocytes. C57BL/6 splenocytes were treated with different concentrations of histamine (10-4 M to 10-11 M). Histamine at higher concentration (10-4 M) increased ERK2 phosphorylation. There was, however no significant effect seen at other concentrations (10-6 M - 10-11 M). Surprisingly, H1 receptor agonist betahistine (10-5 M), H2 agonist amthamine (10-5 M), H3 agonist methimepip (10 -6 M) and H4 agonist 4-methyl histamine (10-6 M), all increased ERK2 phosphorylation. H1R antagonist pyrilamine (10-6 M), H2R antagonist ranitidine (10-5 M), H3/H4R antagonist thioperamide (10-6 M), and H3R antagonist clobenpropit (10-5 M) inhibited histamine mediated ERK2 phosphorylation suggesting that all four histamine receptor subtypes played some role in this phosphorylation. Since TNF-alpha causes phosphorylation of ERK1/2, we investigated whether histamine acted via secretion of TNF-alpha to affect ERK1/2 phosphorylation. As a consequence, TNF-alpha knockout mice were used and we found that TNF-alpha was involved in ERK2 phosphorylation. There was complete inhibition of ERK2 phosphorylation by histamine via H2, H3 and H4 agonists, but effects of H1 agonist were inconclusive in TNF-alpha knockout splenocytes. This suggested that histamine indirectly affected the ERK2 phosphorylation via its effects on the secretion of TNF-alpha and H1 receptor played a role in this process. We performed similar experiments with stress activated protein kinases/c-jun N-terminal kinases (SAPK/JNK). C57BL/6 mice splenocytes were treated with different concentrations of histamine (10-4 M to 10 -11 M), phorbol 12 myristate 13-acetate (PMA) was used as a positive control and phosphorylation of SAPK/JNK was determined. Histamine inhibited phosphorylation of SAPK/JNK at high concentrations (10-4 M-10-8 M) and had no effect on SAPK/JNK phosphorylation at lower concentrations (10 -9 M- 10-11 M). Histamine receptor specific agonists were used to identify the histamine receptors involved in the inhibition of SAPK/JNK phosphorylation. H1R agonist betahistine (10-5 M) decreased the phosphorylation of SAPK/JNK. The decrease in SAPK/JNK phosphorylation by histamine was predominantly an H1 receptor effect. H2R agonist amthamine (10-5 M) did not show any significant effect on SAPK/JNK phosphorylation. H3R agonist methimepip (10-6 M) and H4R agonist 4-methyl histamine (10-6 M), increased SAPK/JNK phosphorylation. H1R antagonist pyrilamine (10-6 M), H2R antagonist ranitidine (10-5 M), H3/H4R antagonist thioperamide (10-6 M), and clobenpropit (10-5 M), partially reversed the histamine mediated inhibition of SAPK/JNK phosphorylation. TNF-alpha knockout mice were used to determine if histamine regulated SAPK/JNK phosphorylation via TNF-alpha. In TNF-alpha knockout mice splenocytes, histamine inhibited SAPK/JNK phosphorylation. Activation of H1 receptors inhibited SAPK/JNK phosphorylation in knockout as was the case in wild type mice. Histamine via H2 receptor inhibited SAPK/JNK phosphorylation in knockout mice, but did not show any significant effect in wild type mice. Activation of H3 receptors decreased SAPK/JNK phosphorylation in knockout mice, as opposed to an increase in wild type mice suggesting that another cytokine besides TNF-alpha was involved in SAPK/JNK phosphorylation. H4 receptor did not show any significant effect in knockout mice, but showed an increase in SAPK/JNK phosphorylation in wild type mice suggesting that TNF-alpha is required for histamine mediated effects via H4 receptors. This data showed a role of TNF-alpha in histamine-mediated effects of SAPK/JNK phosphorylation via H4 receptors.
This website uses cookies to ensure you get the best experience on our website.